Top Markets
Coin of the day
Anbio Biotechnology Class A Ordinary Shares Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology Class A Ordinary Shares

NNNN
Rangering i aksjer #16102
Anbio Biotechnology, established in 2021 and based in Frankfurt am Main,... Anbio Biotechnology, established in 2021 and based in Frankfurt am Main, Germany, operates as a global supplier of in vitro diagnostics (IVD) products. The company's international footprint covers regions such as the European Union, Asia Pacific, North America, South America, and Africa. Their product range features various diagnostic solutions, including rapid antigen tests for SARS-CoV-2 (both individual and combined with influenza A/B). Anbio also develops and manufactures products leveraging advanced technologies like lateral flow immunoassay, fluorescence immunoassay, loop-mediated isothermal amplification (LAMP), chemiluminescence immunoassay (CLIA), and reverse-transcription polymerase chain reaction (RT-PCR). These offerings cater to a wide array of markets, including over-the-counter sales, point-of-care testing, and traditional laboratory settings.
Aksjekurs
$7.15
Markedsverdi
$313.60M
Endring (1 dag)
-2.12%
Endring (1 år)
-84.14%
Land
DE
Handel Anbio Biotechnology Class A Ordinary Shares (NNNN)

Kategori

Aksjeprishistorikk for Anbio Biotechnology Class A Ordinary Shares (NNNN)
Høyeste sluttskurs: $7.15 den 2026-09-01

Laveste sluttskurs: $6.12 den 2025-02-01
Aksjeprishistorikk for Anbio Biotechnology Class A Ordinary Shares fra 2025 til 2026
Årlig aksjeprisytelse
År Ytelse
2026 (TTM) -23.17%
2025 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
$368.46 -22.15%
US
$188.84 -37.67%
FR
$162.52 24.14%
JP
$187.34 23.49%
US
$75.35 -5.80%
CH